O&G SAQs · Gynaecological health — menstrual physiology
The normal menstrual cycle & HPO axis — structured SAQ (15 marks)
FRANZCOG-format structured SAQ on the HPO axis: classifying anovulation by gonadotrophin profile, the two-cell two-gonadotrophin theory, confirming ovulation, and the management and consequences of functional hypothalamic amenorrhoea. Per-sub-part marking rubric included.
On this page
Study tools
Target exams
FRANZCOGMRCOGABOG
Prompt
A 26-year-old presents with secondary amenorrhoea for 8 months after losing 12 kg through intense training and dietary restriction; she is otherwise well. (a) Using the gonadotrophin profile, classify where the hypothalamic-pituitary-ovarian axis is failing and the pattern you expect on day-3 bloods. (4 marks) (b) Explain the two-cell two-gonadotrophin theory and use it to describe why this woman is hypo-oestrogenic. (4 marks) (c) Outline how you would confirm whether she is ovulating, naming the test and its timing. (3 marks) (d) Outline the principles of restoring the axis in this woman (not seeking pregnancy) and the risk of leaving the hypo-oestrogenic state untreated. (4 marks)
How this SAQ is marked
Twelve SAQs, 180 marks, roughly 15 marks and 20 minutes each. Marks come from specifics: the cells matched to the gonadotrophins, the timing of the LH surge and ovulation, the right test timed to the cycle, and the named level of the axis. Write in short labelled points. [1]
Reveal model answer and mark schemeShowHide
(a) Classify the level of axis failure (4 marks)
One mark per point, maximum four. [1][4]
- Hypogonadotropic hypogonadism — an energy deficit from training and dietary restriction has silenced the GnRH pulse generator, so FSH, LH and oestradiol are all low.[3][4]
- Expected day-3 pattern: low FSH, low LH, low oestradiol — the hypothalamic/pituitary level.[1]
- Contrast the profile to localise: low = hypothalamus/pituitary; normal = PCOS; high (FSH) = premature ovarian insufficiency.[4][5]
- Exclude mimics before concluding: pregnancy (always), thyroid disease, hyperprolactinaemia.[3]
(b) Two-cell two-gonadotrophin theory (4 marks)
One mark per point. [1]
- LH receptors are on theca cells, where LH drives androgen (androstenedione) synthesis.
- FSH receptors are on granulosa cells, where FSH induces aromatase, converting theca-derived androgens to oestrone and then oestradiol.
- Oestradiol synthesis therefore needs both cell types and both gonadotrophins.[1]
- This woman is hypo-oestrogenic because her FSH and LH are suppressed (no GnRH pulses), so neither theca nor granulosa are driven — the two-cell cooperation stalls and the follicle cannot make the oestradiol needed for the endometrium.[1][3]
(c) Confirming ovulation (3 marks)
- The single best test of ovulation is a midluteal serum progesterone (about day 21 of a 28-day cycle, or 7 days before the expected next menses).
- A value in the ovulatory range confirms a functioning corpus luteum.
- In an amenorrhoeic woman, ovulation cannot be timed this way; the first objective is to restore cycles, then confirm ovulation with a midluteal progesterone in a subsequent cycle.[1]
(d) Restoring the axis and the risk of non-treatment (4 marks)
- First-line is restoring energy availability — nutrition, weight restoration, reducing training intensity — because the lesion is functional, not structural.
- If cycles do not return, evaluate for other causes and consider oestrogen replacement.
- Oestrogen replacement protects bone and cardiovascular health in the woman not seeking pregnancy.[3]
- Risk of leaving it untreated: progressive bone loss (and cardiovascular/sexual-health morbidity) from chronic hypo-oestrogenism; reassurance without action is not safe.[3]
References5ShowHide
- [1]Reed BG, Carr BR The Normal Menstrual Cycle and the Control of Ovulation. Endotext, 2000.PMID 25905282
- [2]Mihm M, Gangooly S, Muttukrishna S The normal menstrual cycle in women. Anim Reprod Sci, 2011.PMID 20869180
- [3]Shaw ND, Seminara SB, Welt CK, et al. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab, 2011.PMID 21209029
- [4]Munro MG, Balen AH, Cho S, et al. The FIGO ovulatory disorders classification system. Int J Gynaecol Obstet, 2022.PMID 35983674
- [5]Lie Fong S, Schipper I, Valkenburg O, et al. The role of anti-Müllerian hormone in the classification of anovulatory infertility. Eur J Obstet Gynecol Reprod Biol, 2015.PMID 25666342